Increased levels of osteopontin in sputum supernatant in patients with COPD Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Cigarette smoking induced elevated CXCL5 levels in BALF and plasma of patients with COPD Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018
Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003
Osteopontin expression is increased in serum, BAL and bronchial tissue of asymptomatic smokers Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL Source: Eur Respir J 2005; 26: Suppl. 49, 298s Year: 2005
Potential association between cigarette smoking and IL-18 levels in induced sputum of healthy and asthma smokers Source: Eur Respir J 2007; 30: Suppl. 51, 363s Year: 2007
Cigarette smoking modifies the association between IL-18 levels in induced sputum and airway heperresponsiveness in asthmatics Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
Leptin levels in induced sputum from patients with COPD are sensitive to smoking status Source: Eur Respir J 2005; 26: Suppl. 49, 660s Year: 2005
Increased activin-a expression in serum, BAL and bronchial tissue of asthmatic patients Source: Annual Congress 2009 - Novel approaches in asthma Year: 2009
Induction-related changes in sputum neutrophils are associated with increased sputum levels of IL-8, but not sICAM Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002
Increased levels of angiopoietin 1 & 2 in sputum supernatant in smoking asthma Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Elevation of surfactant protein A in plasma and sputum in cigarette smokers Source: Eur Respir J 2011; 38: 277-284 Year: 2011
Age related alterations in sputum and plasma MMP-9 and TIMP-1 levels in healthy non-smokers and smokers Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010
Role of sputum eosinophil levels in the assessment of asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004
Proteolytic activity of sputum and serum in patients with COPD exacerbation in dependence on smoking Source: Eur Respir J 2003; 22: Suppl. 45, 416s Year: 2003
Increased sputum concentrations of total glutathion in patients with COPD who quit smoking Source: Eur Respir J 2001; 18: Suppl. 33, 365s Year: 2001
The influence of steroidotherapy in COPD exacerbation on matrix metalloproteinase MMP-9 level in BAL, induced sputum and serum Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Sputum MMP-12 concentration and enzyme activity in COPD and asthma in relation to smoking status and disease severity Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010
Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Elevated IL-8 levels in BAL fluid of individuals working in asbestos mine Source: Eur Respir J 2003; 22: Suppl. 45, 121s Year: 2003